NCT00560170View on ClinicalTrials.gov

Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

February 29, 2008

Conditions
Atherosclerosis
Interventions
DRUG

Simvastatin (Zocor)

40mg of Simvastatin (n=20) orally per-day for 28 days

DRUG

10mg/10mg of Ezetimibe/Simvastatin (Vytorin)

10mg/10mg of Ezetimibe/Simvastatin (n=20) orally per-day for 28 days

Trial Locations (1)

704

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER

NCT00560170 - Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis | Biotech Hunter | Biotech Hunter